GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
about
Role of DNA methylation in renal cell carcinomaRenal cancer biomarkers: the promise of personalized careAberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma.Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and MetastasisHsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinomaTumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
P2860
Q26801268-8AC40C88-572E-4A52-81D0-1F485D50D307Q34422845-6A9F43F9-4823-41A1-96ED-CDCF4353867EQ34609542-0AB8A3B4-50B4-4736-A9A3-E26F74E65B99Q35016547-672CC37A-B083-4595-B03C-36A159E74099Q35095715-AE9C75A7-6B73-445C-B8FD-F5C23BE328FFQ36150977-28EF9274-1778-4B89-BA60-2174DE308212Q36557866-E4FACD84-3D5B-4218-AD06-0AAAD8D21224Q37484160-8D7BE5AC-985E-435D-9AA5-F30ED388DA86Q37685151-95CB630F-C7AD-449E-9F54-40794DAD4A08Q37703383-69157879-A541-4FCB-9DE2-E437C24855A8Q38833395-AA92EDC3-F039-4C39-B18B-5D109B9CDC81Q48019854-04ED5BB0-141A-4E6E-A12F-A6C052A43D8E
P2860
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
GATA5 CpG island methylation i ...... tasis and disease progression.
@en
GATA5 CpG island methylation i ...... tasis and disease progression.
@nl
type
label
GATA5 CpG island methylation i ...... tasis and disease progression.
@en
GATA5 CpG island methylation i ...... tasis and disease progression.
@nl
prefLabel
GATA5 CpG island methylation i ...... tasis and disease progression.
@en
GATA5 CpG island methylation i ...... tasis and disease progression.
@nl
P2093
P2860
P1433
P1476
GATA5 CpG island methylation i ...... tasis and disease progression.
@en
P2093
Anika Grosshennig
Arnulf Stenzl
Axel S Merseburger
Faranaz Atschekzei
Hendrik Eggers
Inga Peters
Jörg Hennenlotter
Jürgen Serth
Markus A Kuczyk
Sandra Waalkes
P2860
P304
P356
10.1111/J.1464-410X.2011.10862.X
P433
P577
2012-01-30T00:00:00Z